ForumIAS LATEST
- 23 August | Your preparation may need an environment, not another course Click Here to Read More →
- 17 August | Navigating the Crest & Trough of Rankforgers by Mr. Ayush Sinha Click Here to Watch →
- 16 August | Are you the Average of the 5 People Around You by Mr. Ayush Sinha | Click Here to Watch →
Source : Click here
News: A new drug called Molnupiravir has been shown to stop the transmission of SARS-CoV-2 (COVID-19) in 24 hours.
Facts:
- Molnupiravir: It is an experimental antiviral drug which is orally active (can be taken orally) and was developed for the treatment of influenza.
- Developed by: The drug is being developed by the biotechnology firm Ridgeback Biotherapeutics in collaboration with pharmaceutical firm Merck.
- Significance: This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission and it can be a game-changer
